Skip to main navigation

The link is opening in a new window or tab that may or may not accessible Opens an external site Opens an external site in a new window

Pre-Header Contact

800-449-3353 | custserv@rockwellmed.com |

Footer Socials

Pre-Header Menu

Careers | Contact Us

Client Header Links

Home
Our Company
Our Therapeutic Focus
Our Technology
Hemodialysis Concentrates
Investors

Investor Relations

Press Releases

Main navigation

Investor Home
Press Releases
Events & Presentations
Corporate Governance
Management
Annual Meeting
Financial Information
Stock Information
Investor FAQs
Contact Us
Shareholder Tools

Press Releases

Year

Feb 14, 2022

Rockwell Medical Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PDF Version

Jan 20, 2022

Rockwell Medical Announces Regulatory Approval of Triferic® Dialysate in South Korea

PDF Version

Jan 13, 2022

Rockwell Medical Announces Regulatory Approval of Triferic® AVNU in South Korea

PDF Version

Jan 07, 2022

Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2022 Conference

PDF Version

Pagination

First page
Previous page
Page 1
Current page 2

Shareholder Tools

Snapshot

Email Alerts

RSS News Feeds

Have any questions?

Phone 248 432-1997

invest@rockwellmed.com

Client Header Links

Home
Our Company
Our Therapeutic Focus
Our Technology
Hemodialysis Concentrates
Investors
Contact

Footer Socials